Phreesia, Inc. (NYSE:PHR) COO Sells $348,175.19 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 12,749 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $27.31, for a total value of $348,175.19. Following the sale, the chief operating officer now directly owns 755,459 shares of the company’s stock, valued at $20,631,585.29. This represents a 1.66 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Evan Roberts also recently made the following trade(s):

• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The stock was sold at an average price of $27.95, for a total transaction of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Price Performance

Shares of NYSE:PHR traded down $0.06 during trading on Wednesday, reaching $27.29. The stock had a trading volume of 389,445 shares, compared to its average volume of 386,096. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $29.16. The stock has a market cap of $1.59 billion, a PE ratio of -18.56 and a beta of 0.94. The business has a fifty day moving average price of $23.77 and a 200-day moving average price of $22.94.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business’s revenue was up 16.6% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.58) earnings per share. On average, equities analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Robert W. Baird lowered their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Friday, January 10th. KeyCorp upped their price target on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. Citigroup upped their target price on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Finally, Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price target for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $31.00.

Institutional Investors Weigh In On Phreesia

A number of institutional investors have recently made changes to their positions in PHR. International Assets Investment Management LLC increased its stake in shares of Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after buying an additional 1,395 shares during the period. Lombard Odier Asset Management USA Corp purchased a new stake in shares of Phreesia in the 2nd quarter valued at approximately $202,000. Point72 DIFC Ltd acquired a new stake in shares of Phreesia in the 2nd quarter valued at $209,000. XTX Topco Ltd acquired a new stake in shares of Phreesia in the 3rd quarter valued at $247,000. Finally, Hsbc Holdings PLC purchased a new stake in shares of Phreesia during the 2nd quarter worth $301,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.